Dr. Kazmi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-4673Fax+1 214-645-2542- Is this information wrong?
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2007 - 2010
- Aga Khan Medical CollegeClass of 2004
Certifications & Licensure
- TX State Medical License 2017 - 2024
- NM State Medical License 2013 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib Start of enrollment: 2017 Jun 07
- Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study Start of enrollment: 2019 Nov 22
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Transferring care to enhance access to early-phase cancer clinical trials: Protocol to evaluate a novel program.Chika Nwachukwu, Sukh Makhnoon, Marieshia Person, Meera Muthukrishnan, Kandice A Kapinos, Erin L Williams, Oluwatomilade Fatunde, Fabian Robles, Alice Basey, Thomas Hu...> ;Contemporary Clinical Trials Communications. 2024 Jun 1
- The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial.David Hsiehchen, Muhammad S Beg, Radhika Kainthla, Jay Lohrey, Syed M Kazmi, Leticia Khosama, Mary Claire Maxwell, Heather Kline, Courtney Katz, Asim Hassan, Naoto Kub...> ;Nature Communications. 2024 Mar 11
- 1 citationsCharacteristics and clinical outcomes in young-onset cholangiocarcinoma.Sarah Reddy, Nina N Sanford, Radhika Kainthla, David Hsiehchen, Aravind Sanjeevaiah, Amy L Jones, Georgios Karagkounis, Salwan Al Mutar, Chul Ahn, Muhammad S Beg, Syed...> ;Cancer Medicine. 2023 Jul 1
- Join now to see all
Press Mentions
- jb1-802 by JubilantSeptember 30th, 2021
- Jubilant Therapeutics Strengthens Board of Directors with Addition of Leila Alland, M.D. And Announces Appointment of Jeremy Barton, M.D., as Strategic Advisor and Interim CMOAugust 16th, 2021
- Jubilant Therapeutics Announces Appointment of Luca Rastelli, Ph.D. As Chief Scientific OfficerMarch 8th, 2021
- Join now to see all
Hospital Affiliations
- University of Texas Southwestern Medical CenterDallas, Texas
- Parkland HealthDallas, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: